Bilberry

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: heart inflammation skin

Research Overview

Across the abstracts, bilberry (Vaccinium myrtillus L.) research is most concentrated on its phytochemical composition—especially anthocyanins and other phenolics—and on mechanistic links to inflammation and oxidative stress. Multiple reviews emphasize bilberry fruit as a “functional food” rich in anthocyanins, alongside non-anthocyanin phenolics, vitamins, organic acids, sugars, and fiber, and note growing interest in valorizing bilberry fruit and by-products for food and pharmaceutical applications. A smaller but notable strand focuses on formulation science (e.g., encapsulation) to improve polyphenol stability and bioavailability, and on expanding attention beyond fruits to phenolic constituents in bilberry leaves. Disease-oriented discussions most frequently place bilberry within broader polyphenol research for metabolic disorders (including type 2 diabetes) and inflammatory conditions (including inflammatory bowel disease), as well as oxidative-stress–related eye health.

The strongest support in these abstracts is for anti-inflammatory and antioxidant-related effects, with convergent preclinical evidence and some supportive clinical findings. Mechanistic studies (cell/animal models) consistently implicate down-regulation of pro-inflammatory cytokines (e.g., TNF-α, IL-6, IL-1β) and modulation of inflammatory signaling pathways (e.g., NF-κB and JAK/STAT), alongside effects on inflammatory enzymes and oxidative defense. Clinically, the most consistent signal described is that bilberry supplementation (as whole berries, juices, or anthocyanin preparations) can reduce inflammatory markers in studies of metabolic disorders, though the abstracts do not establish definitive clinical endpoints or standardized dosing. In IBD, reviews describe plausible protective/therapeutic mechanisms for bilberry anthocyanins and related polyphenols, but emphasize that evidence remains incomplete and that translation from mechanistic findings to patient outcomes is not yet definitive.

Key gaps highlighted include bioavailability and real-world efficacy: despite extensive in vitro work, human in vivo evidence—particularly for encapsulated bilberry polyphenols—remains limited and inconsistent, with encapsulation showing clearer benefits for some single compounds than for complex mixtures such as bilberry anthocyanins. More rigorous, well-controlled human trials are needed to determine effective doses, formulations (whole fruit vs. extracts vs. encapsulated products), duration of use, and clinically meaningful outcomes in metabolic disease, IBD, and eye-related conditions. Additional needs include better characterization of leaf-derived phenolics, standardized extract composition and reporting, and deeper investigation of gut microbiome interactions that may mediate bilberry polyphenol metabolism and downstream effects.

1. What conditions has Bilberry been studied for?

  • Type 2 diabetes mellitus (T2DM) and metabolic disorders: Mentioned among natural products considered for prevention/amelioration of T2DM-related complications; bilberry supplementation was also discussed in clinical studies of metabolic disorders where inflammatory markers were assessed.

  • Inflammation and chronic inflammatory disorders: A dedicated review summarized anti-inflammatory mechanisms and clinical studies (mostly in metabolic disorders) assessing inflammatory biomarkers.

  • Inflammatory bowel disease (IBD): Bilberry anthocyanins are discussed as polyphenols with potential protective/therapeutic effects in IBD; a preclinical study investigated bilberry anthocyanin extracts in DSS-induced intestinal inflammation (animal model).

  • Eye/ophthalmic conditions: Discussed in the context of oxidative stress and age-related eye diseases; bilberry extract was reported to prevent impairments in lenses and retina and alleviate dry eye symptoms (summary-level statement in a review).

  • Cancer prevention/supportive health: A review of bilberry/bog bilberry notes antioxidant/anti-inflammatory/anti-cancer and apoptosis-reducing activity and suggests use in prevention contexts (broad claim; details not provided in the abstract).

  • Immune function/inflammation modulation: Included in a narrative review of nutrients/phytonutrients affecting immune function and inflammation (e.g., NF-κB, TNF-α, IL-6 and other immune markers were discussed across interventions, including bilberry).

  • Hypoglycemic activity (mechanistic/preclinical): Bilberry leaf extracts (microencapsulated powders) showed strong in vitro α-glucosidase inhibitory activity (a mechanism relevant to postprandial glucose control).

  • Bioavailability/encapsulation research: Human in vivo studies have examined whether encapsulation improves bioavailability of polyphenols including bilberry anthocyanins (results inconsistent).

2. Does it work in treating those conditions? Summarize the evidence.

  • Metabolic disorders / inflammation biomarkers (human clinical evidence, mixed but generally supportive):

    • A review focused on bilberry anti-inflammatory properties reports that bilberry supplementation (as fruits, juices, or anthocyanins) reduced inflammatory markers in most clinical studies of metabolic disorders. The abstract does not specify which markers or effect sizes, but it indicates a trend toward benefit.

    • A broader T2DM review positions bilberry among natural products that may help prevent/ameliorate T2DM-related complications and suggests potential value as an adjunct to pharmacotherapy, but it does not provide trial-level outcomes in the abstract.

  • IBD (mostly preclinical; clinical evidence not established):

    • An IBD polyphenol review states that research supports protective/therapeutic effects of dietary polyphenols via down-regulating inflammatory cytokines/enzymes and suppressing inflammatory pathways, and it includes bilberry anthocyanin among the polyphenols discussed; however, it explicitly notes that further preclinical and clinical studies are needed to clarify safety, bioavailability, and bioefficacy in IBD patients.

    • A separate study investigated bilberry anthocyanin extracts in a DSS-induced intestinal inflammation model (animal model), supporting plausibility but not confirming efficacy in humans.

  • Eye/vision outcomes (suggestive but not definitive):

    • A review on antioxidants and ophthalmic diseases reports that bilberry extract prevented impairments in lenses and retina and alleviated symptoms of dry eye disease, but also emphasizes that further studies with clinical measurements are required to establish effectiveness.

  • Cancer prevention (insufficient detail in provided abstracts):

    • A bilberry/bog bilberry review states that clinical studies confirm benefits of supplementation as part of a healthy diet and highlights antioxidant/anti-inflammatory/anti-cancer and apoptosis-reducing activity, but the abstract does not provide specific cancer endpoints, populations, or effect estimates.

  • Encapsulation to improve effects (human evidence inconsistent for bilberry anthocyanins):

    • A review of in vivo human studies concludes that encapsulation improves bioavailability for some individual polyphenols (e.g., curcumin, hesperidin, fisetin), but results are not consistent for groups of polyphenols such as bilberry anthocyanins. This suggests that formulation strategies may or may not enhance bilberry anthocyanin exposure in humans.

  • Glucose-lowering mechanisms (preclinical/in vitro):

    • Microencapsulated bilberry leaf extract powders showed strong α-glucosidase inhibitory activity (IC50 values reported as 5.00–19.59 µg/mL) and were described as preserving hypoglycemic bioactivity; this is mechanistic and does not confirm clinical glucose lowering.

3. What health benefits does it have?

  • Anti-inflammatory effects: Reviews report bilberry phytochemicals (including anthocyanins and other phenolics) and describe anti-inflammatory actions in cell/animal models (e.g., lowering TNF-α, IL-6, IL-1β; modulation of NF-κB and JAK-STAT pathways). In humans, bilberry supplementation reduced inflammatory markers in most clinical studies in metabolic disorders (per the anti-inflammatory review).

  • Antioxidant activity: Bilberry is repeatedly characterized as rich in anthocyanins and other phenolics with antioxidant properties; this is linked in reviews to potential benefits across chronic diseases and eye health.

  • Potential metabolic support: Positioned as a natural product that may help prevent/ameliorate T2DM-related complications; bilberry leaf extracts show α-glucosidase inhibition in vitro (a plausible mechanism for reducing postprandial glucose excursions).

  • Potential gastrointestinal/IBD relevance: Polyphenol reviews include bilberry anthocyanins as candidates for IBD management via inflammatory pathway modulation, though clinical confirmation is lacking.

  • Potential eye-health support: A review suggests bilberry extract may help prevent lens/retina impairments and alleviate dry eye symptoms, but emphasizes the need for more rigorous clinical measurement.

  • Food and micronutrient/phytochemical value: A bilberry fruit characterization review describes bilberry as a source of micronutrients and phytochemicals (organic acids, sugars, vitamins, fibers, phenolic compounds including anthocyanin and non-anthocyanin compounds), supporting its role as a “functional food.”

4. Does it have any downsides or side effects?

  • Side effects not clearly defined in the provided abstracts: None of the bilberry-focused abstracts included here provide specific adverse event rates, contraindications, or clinically characterized side effects.

  • Evidence limitations and uncertainty: Multiple reviews emphasize that more studies are needed—particularly for IBD and ophthalmic outcomes—to clarify safety, bioavailability, and bioefficacy in patient populations.

  • Bioavailability challenges: Polyphenol bioactivity can be compromised by low bioavailability; encapsulation strategies have shown inconsistent improvements for bilberry anthocyanins in human in vivo studies, which could limit real-world effectiveness even if the compounds are active in vitro.

  • Adjunct—not replacement—framing in diabetes: The T2DM review highlights harms/side effects of long-term pharmacotherapy and discusses natural products as potentially safer alternatives or adjuncts, but it does not establish bilberry as a substitute for standard care; relying on supplements alone could be a practical downside if it delays effective treatment.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

No pharmacogenomic findings are described in the provided abstracts for bilberry (e.g., no gene–supplement interactions, genotype-stratified responses, or variant-specific safety signals). Current evidence in these abstracts does not allow conclusions about whether bilberry is beneficial or harmful for specific genetic variations.

References

  1. Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus.
    Jana Blahova, Monika Martiniakova, Martina Babikova, Veronika Kovacova, Vladimira Mondockova, Radoslav Omelka (2021) - Pharmaceuticals (Basel, Switzerland)
  2. Phenolic Compounds from Five Ericaceae Species Leaves and Their Related Bioavailability and Health Benefits.
    Bianca Eugenia Ștefănescu, Katalin Szabo, Andrei Mocan, Gianina Crişan (2019) - Molecules (Basel, Switzerland)
  3. Lingonberry (
    Katarzyna Kowalska (2021) - International journal of molecular sciences
  4. Does Encapsulation Improve the Bioavailability of Polyphenols in Humans? A Concise Review Based on In Vivo Human Studies.
    Ali Ali Redha, Chamali Kodikara, Daniel Cozzolino (2024) - Nutrients
  5. Vaccinium myrtillus L. Fruits as a Novel Source of Phenolic Compounds with Health Benefits and Industrial Applications - A Review.
    Tânia C S P Pires, Cristina Caleja, Celestino Santos-Buelga, Lillian Barros, Isabel C F R Ferreira (2020) - Current pharmaceutical design
  6. The role of dietary polyphenols in the management of inflammatory bowel disease.
    Mohammad H Farzaei, Roja Rahimi, Mohammad Abdollahi (2015) - Current pharmaceutical biotechnology
  7. Two genes, ANS and UFGT2, from Vaccinium spp. are key steps for modulating anthocyanin production.
    Han M Nguyen, Joanna Putterill, Andrew P Dare, Blue J Plunkett, Janine Cooney, Yongyan Peng, Edwige J F Souleyre, Nick W Albert, Richard V Espley, Catrin S Günther (2023) - Frontiers in plant science
  8. Anti-Inflammatory Activity of Bilberry (
    Anshul Sharma, Hae-Jeung Lee (2022) - Current issues in molecular biology
  9. Bilberries: Curative and Miraculous - A Review on Bioactive Constituents and Clinical Research.
    Zuzana Vaneková, Judith M Rollinger (2022) - Frontiers in pharmacology
  10. There and back again; historical perspective and future directions for
    Patrick P Edger, Massimo Iorizzo, Nahla V Bassil, Juliana Benevenuto, Luis Felipe V Ferrão, Lara Giongo, Kim Hummer, Lovely Mae F Lawas, Courtney P Leisner, Changying Li, Patricio R Munoz, Hamid Ashrafi, Amaya Atucha, Ebrahiem M Babiker, Elizabeth Canales, David Chagné, Lisa DeVetter, Mark Ehlenfeldt, Richard V Espley, Karina Gallardo, Catrin S Günther, Michael Hardigan, Amanda M Hulse-Kemp, MacKenzie Jacobs, Mary Ann Lila, Claire Luby, Dorrie Main, Molla F Mengist, Gregory L Owens, Penelope Perkins-Veazie, James Polashock, Marti Pottorff, Lisa J Rowland, Charles A Sims, Guo-Qing Song, Jessica Spencer, Nicholi Vorsa, Alan E Yocca, Juan Zalapa (2022) - Horticulture research
  11. Protective Effect of Bilberry Anthocyanin Extracts on Dextran Sulfate Sodium-Induced Intestinal Damage in
    Guocai Zhang, Yunyao Gu, Xianjun Dai (2022) - Nutrients
  12. Review of Evidence for the Usage of Antioxidants for Eye Aging.
    Priscilla Peixi Choo, Pui Juan Woi, Mae-Lynn Catherine Bastion, Rokiah Omar, Mushawiahti Mustapha, Norshamsiah Md Din (2022) - BioMed research international
  13. Microencapsulated Bilberry and Chokeberry Leaf Extracts with Potential Health Benefits.
    Snežana Kuzmanović Nedeljković, Milica Radan, Nada Ćujić Nikolić, Zorana Mutavski, Nemanja Krgović, Smilja Marković, Tatjana Stević, Jelena Živković, Katarina Šavikin (2023) - Plants (Basel, Switzerland)
  14. Vaccinium uliginosumandVaccinium myrtillus-Two Species-One Used as a Functional Food
    Agnieszka Kopystecka, Ilona Kozioł, Dominika Radomska, Krzysztof Bielawski, Anna Bielawska (2023)
  15. The effects of twenty-four nutrients and phytonutrients on immune system function and inflammation: A narrative review.
    Jillian Poles, Elisa Karhu, Megan McGill, H Reginald McDaniel, John E Lewis (2021) - Journal of clinical and translational research
  16. A single supplement of a standardised bilberry (Vaccinium myrtillus L.) extract (36 % wet weight anthocyanins) modifies glycaemic response in individuals with type 2 diabetes controlled by diet and lifestyle.
    Nigel Hoggard, Morven Cruickshank, Kim-Marie Moar, Charles Bestwick, Jens J Holst, Wendy Russell, Graham Horgan (2013) - Journal of nutritional science
  17. Green Approach to Enhance the Recovery of Polyphenols from Blackcurrant and Bilberry Leaves: Evaluation of Microwave-Assisted and Pressurized Liquid Extraction.
    Ivona Elez Garofulić, Maja Repajić, Ena Cegledi, Erika Dobroslavić, Ana Dobrinčić, Zoran Zorić, Sandra Pedisić, Tatjana Franković, Martina Breški, Verica Dragović-Uzelac (2024) - Molecules (Basel, Switzerland)
  18. A chromosome-scale assembly of the bilberry genome identifies a complex locus controlling berry anthocyanin composition.
    Chen Wu, Cecilia Deng, Elena Hilario, Nick W Albert, Declan Lafferty, Ella R P Grierson, Blue J Plunkett, Caitlin Elborough, Ali Saei, Catrin S Günther, Hilary Ireland, Alan Yocca, Patrick P Edger, Laura Jaakola, Katja Karppinen, Adrian Grande, Ritva Kylli, Veli-Pekka Lehtola, Andrew C Allan, Richard V Espley, David Chagné (2022) - Molecular ecology resources
  19. Berries and Their Active Compounds in Prevention of Age-Related Macular Degeneration.
    Xiang Li, Lingda Zhao, Bowei Zhang, Shuo Wang (2024) - Antioxidants (Basel, Switzerland)
  20. Neuroprotective effect of bilberry extract in a murine model of photo-stressed retina.
    Hideto Osada, Tomohiro Okamoto, Hirohiko Kawashima, Eriko Toda, Seiji Miyake, Norihiro Nagai, Saori Kobayashi, Kazuo Tsubota, Yoko Ozawa (2017) - PloS one


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!